Evidence map›Paper›PMID 41869439›Full record

ArticleJournal of Cancer2026

Proteasome Assembly Chaperone 3 Defines Metabolic-Immune Programs and Poor Prognosis in Breast Cancer via Multi-Omics Approaches.

Sachin Kumar, Hoang Dang Khoa Ta, Hao-Chien Yang, Chia-Lung Shih, Dahlak Daniel Solomon, Ching-Chung Ko, Do Thi Minh Xuan, Yung-Kuo Lee, Kai-Fu Chang, Hui-Ru Lin and 5 more

Abstract read
In one paragraph

Article in Journal of Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Sachin KumarPhD Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.
Hoang Dang Khoa TaPhD Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.
Hao-Chien YangDepartment of Surgery, Division of Neurosurgery, Shuang Ho Hospital, Taipei Medical University New Taipei City 23561, Taiwan.
Chia-Lung ShihClinical Research Center, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi City 60002, Taiwan.
Dahlak Daniel SolomonPhD Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.
Ching-Chung KoDepartment of Medical Imaging, Chi-Mei Medical Center, Tainan 710402, Taiwan.
Do Thi Minh XuanVan Lang University, 69/68 Dang Thuy Tram Street, Binh Loi Trung Ward, Ho Chi Minh City, Vietnam.
Yung-Kuo LeeSchool of Medicine, National Defense Medical University, Taipei 11490, Taiwan.
Kai-Fu ChangMedical Laboratory, Medical Education and Research Center, Kaohsiung Armed Forces General Hospital, National Defense Medical University, Kaohsiung 80284, Taiwan.
Hui-Ru LinInstitute of Medical Science and Technology, National Sun Yat-Sen University, Kaohsiung 80424, Taiwan.
Shu-Huei KaoPh.D. Program in Medical Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
Jian-Ying ChuangThe Ph.D. Program for Neural Regenerative Medicine, Taipei Medical University, Taipei 11031, Taiwan.
Jian-Bin ChenDepartment of Radiology, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi, Taiwan.
Chih-Yang WangPhD Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.
Ngoc Uyen Nhi NguyenCenter for Regenerative Medicine, University of South Florida Health Heart Institute, Tampa, FL 33602, U.S.A.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The proteasome assembly chaperone (

Indexed as

breast cancerfatty acid metabolismhypoxiaimmune infiltrationPSMG3 (proteasome assembly chaperone 3)single-cell sequencingtumor microenvironment

Identifiers

PMID41869439
PMCPMC13003543

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.